SERA-SCANDIA A/S: Financial statements 2017
CVR: 14605185
Source: annual report 2017, Danish Business Authority
01/04/2016 – 31/03/2017
SERA-SCANDIA A/S (CVR 14605185) has filed annual accounts for 2017. In 2017, the company reported revenue of DKK 2,752,000 and a net result of DKK 8,044,000 compared with DKK 2,867,073 the year before. That is an increase of 2,765.2% compared with the year before. The profit margin was 292.3%. Equity in the 2017 report amounted to DKK 39,870,000. The solvency ratio was 41.9%. The company had 190 employees in the financial year.
- Revenue
- DKK 2,752,000
- Gross Profit
- DKK 1,322,000
- Profit/Loss
- DKK 8,044,000
- Equity
- DKK 39,870,000
- Total Assets
- DKK 95,227,000
- Employees
- 190
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2017 | 2.8M | 1.3M | 8M | 39.9M | 190 |
| 2016 | 96K | -19K | 2.9M | 31.8M | - |
| 2015 | 81K | -18K | -3.7M | 29M | - |
| 2014 | 73K | 52K | -3.5M | 32.7M | - |
| 2013 | 0 | 0 | -8.8M | 36.2M | - |
Official annual report
Keep an eye on SERA-SCANDIA A/S
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringAbout SERA-SCANDIA A/S
SERA-SCANDIA A/S is a Danish company of the type Aktieselskab based in Ballerup, founded in 1990. The company is registered under the industry Fremstilling af farmaceutiske præparater. The company was previously named SERA-SCANDIA ApS and VICH 2604 ApS. The management consists of Troels Zakarias Glahn Kristiansen. The board consists of Ole Bødtker Nielsen (chair), Christian Lykkehus Sørensen and Nicolas Bødtker Nielsen. The company is owned by Danbiotech Inc.. The company has 16 employees (2026). In 2025, the company reported a gross profit of DKK 40,586,000 and a net result of DKK -7,801,000 compared with DKK 2,203,000 the year before. Equity in the 2025 report amounted to DKK 272,104,000.